Navigation Links
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2013
Date:11/27/2013

DUBLIN, November 27, 2013 /PRNewswire/ --


Research and Markets
( http://www.researchandmarkets.com/research/vv9ntz/circulating_tumor) has announced the addition of the "Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2013" report to their offering.
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


This is the latest and most up-to-date Market Report addressing the CTC and CSC markets as they are evolving rapidly.

In this report, the authors focus upon technical and business trends in these spaces as they are fast evolving. CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis. Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.

The authors have performed worldwide market tracking wherein they've analyzed research trends in the study of CTCs and CSCs. Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research activity vis-à-vis CTCs and CSCs are described in this dataset derived from worldwide pools of researchers in November and December 2012therefore these data reflect an up-to-date market landscape.

The authors have also performed extensive analysis of the various clinical trials where CTCs are being enumerated and analyzed. These clinical data set the trajectory of the clinical utility of CTCs.

This data-driven characterization of the CTCs and CSCs landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy developmentall the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling drag-and-drop into business presentations/business plansthis Market Report is written and delivered to customers in Microsoft PowerPoint format.

Extensive Technical and Market Analyses Presented in this Report

- Molecular Characterization of CTCs and CSCs
- Technologies for Studying CTCs
- CTC Analysis Workflow
- Enrichment and Analysis Methodologies
- Details of Selected Approaches for circulating tumor cells Enumeration and Analysis
- Name of Company/Institution
- Microfluidics-based Approaches
- Imaging-based Approaches
- CTC and CSC Research Market Landscape
- Bottom-up Market Survey Data: Qualitative and Quantitative Market Analysis
- Product Vendors and their Penetrance into the Research Market
- Methodologies for Studying CTCs and CSCs
- Markers for Characterizing CTCs and CSCs
- Downstream Analyses on Captured CTCs
- CTC Quantitative Market Metrics
- Revenues from Clinical UtilizationMarket Size, Market Forecast, Growth Rate
- Analysis of Clinical Utility of CTCs
- Evidence for Biomarker Utility of CTCs
- CTC and CSC Clinical Trials Analysis

For more information visit http://www.researchandmarkets.com/research/vv9ntz/circulating_tumor

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
2. Growing Industry in Technologies For Circulating Tumor Cells: Kalorama Report
3. PolyScience Performance Programmable Circulating Baths Deliver Ultra-Precise, Highly Customizable Performance
4. Discovery of Circulating Protein Biomarkers by Analysis of the Tissue Secretome, New Life Science Webinar Hosted by Xtalks
5. Blood-Based Circulating Microvesicles (cMV) Data to be Presented at the 2013 International Society for Extracellular Vesicles (ISEV)
6. PolyScience Heated Circulating Baths Boast Temperature Stabilities as Precise as ±0.005°C
7. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market is Expected to Reach USD 7.9 billion by 2018: Transparency Market Research
8. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
9. Berg Launches First-Ever Stratified Medicine Clinical Trial To Investigate Cancer Metabolism Of Solid Tumors
10. National Brain Tumor Society Announces the Defeat GBM Research Collaborative’s Project Plans and Investigator Teams
11. Quantitative Profiling of the Intrinsic Pathway of Apoptosis in Tumor Tissue Using Myriad RBM’s Multiplex ApoptosisMAP™, a New Biomarker Webinar by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research and Markets ... the addition of the "Implantable Biomaterials Market Analysis ... report to their offering. Report Highlights: ... on current and future market trends to identify the investment opportunities ... base numbers Key market trends across the business segments, ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
(Date:1/19/2017)... ... 19, 2017 , ... FireflySci Inc. is a go-getter type of company that ... accounted to two main factors. The first is the amazing customer service that ... FireflySci products all around the world. , 2016 was a tremendous sales year for ...
(Date:1/19/2017)... 18, 2017 Acupath Laboratories, Inc., a leading ... of an Executive Committee that will guide the company,s ... John Cucci , a 15-year veteran of the ... Business Development to Chief Sales Officer .  Prior ... in senior sales leadership roles at several leading lab ...
Breaking Biology Technology:
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
Breaking Biology News(10 mins):